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ABSTRACT 
In this case series, we report a potentially novel association of corneal collagen crosslinking (CCL) with the development 
of photophobia symptoms in a series of patients at a tertiary ophthalmology clinic and describe their clinical course. 
Photosensitivity is a rare and seemingly unpredictable complication of refractive surgery but can present as a disabling, 
bilateral ocular pain that requires immediate treatment. This complication, termed transient light-sensitivity syndrome 
(TLSS), can have a substantially delayed presentation after ocular procedures and is associated with inflammation of 
structures in the anterior chamber that can be imperceptible on slit-lamp examination. Traditionally, exposure to high-
energy femtosecond lasers is hypothesized to create stromal gas bubbles powering postoperative inflammatory 
reactions. TLSS-like symptoms after CCL may be due to a secondary inflammatory response involving activated 
keratocytes and cytokine release. However, free radical damage from the interaction of riboflavin and ultraviolet in CCL 
may also drive this inflammatory process. 
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INTRODUCTION
Unusual and unpredictable occurrences of 
photosensitivity without changes in visual acuity have 
been reported in several case reports described after 
refractive procedures, such as laser-assisted in situ 
keratomileusis (LASIK) and small incision lenticule 
extraction (SMILE). This complication, termed transient 
light-sensitivity syndrome (TLSS), is characterized by 
moderate-to-severe photophobia bilaterally that appears 
two to eight weeks after ocular procedures and is 
associated with inflammation of peripheral structures, 
such as the ciliary body, and possibly the trabecular 
meshwork and iris [1, 2]. TLSS typically does not present 
with clinical signs of inflammation or any other 
abnormalities of the anterior and posterior segments on 
slit-lamp exam [2, 3]. In our tertiary ophthalmology 
practice, we have observed several cases of acute TLSS-
like symptoms weeks after corneal collagen crosslinking 
(CCL) procedures. CCL uses photopolymerization of 
riboflavin and ultraviolet-A radiation (UVA) to create 
inter- and intrafibrillar covalent bonds within the anterior 
stroma to slow the progression of keratoconus [4-7]. 
Typically, the epithelium is removed (EPI-Off) before CCL; 
however, transepithelial methods have also been used to 
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preserve corneal thickness and reduce post-operative 
pain (EPI-On) [4, 8]. 
In this report, we describe the potential association of 
CCL and TLSS-like symptoms based on our clinical 
observations of patients who received CCL treatment. 
We also speculate possible mechanisms for this 
association. 
CASE DESCRIPTIONS 
Similar to the phenomenon described after refractive 
procedures [2, 3, 9], we have observed a delayed-onset 
photosensitivity in seven of our patients who received 
CCL therapy with either the epithelium removed or kept 
in place. From 2014 to 2019, we have performed CCL in 
125 patients using the Dresden protocol, delivering 3 
milliwatts per square centimeter [mW/cm
2
] UVA for 30 
min (dose = 5.4 joules per centimeter [J/cm]) with the 
FDA-approved KXL® system (Avedro, Waltham, MA). 
Photrexa viscous® (riboflavin 5’-phosphate in 20% 
dextran ophthalmic solution) 0.146% was applied 
topically on the eye for 30 min every two minutes prior 
to irradiation and then every two minutes for the 30-
minute irradiation period. Postoperatively, all patients 
received topical moxifloxacin (Vigamox; Alcon; USA) 0.5% 
(four times daily for one week) and a standard regimen 
of topical prednisolone acetate 1% (four times daily for 
the first week, three times daily for the second week, 
two times daily for the third week, and once daily for the 
fourth week).  
A written informed consent was obtained from each 
patient prior to CCL. This case series was approved by the 
Ethics Board of Hoopes Durrie Rivera Research.  
Of our 125-patient sample, seven individuals experienced 
delayed photosensitivity symptoms similar to TLSS, 
yielding a 5.6% incidence over the last five years. Among 
the seven patients who experienced TLSS symptoms 
post-CCL, five were male, the majority were Caucasian, 
and age ranged from 14 to 54 years old. Additionally, all 
of these patients had stage 2 keratoconus by Amsler-
Krumeich classification [10], prior to CCL treatment. 
More importantly, none of the seven patients had loss of 
corrected distance visual acuity (CDVA) after treatment 
of TLSS-like symptoms. Table 1 outlines our specific 
observations of these patients. Two patients who 
presented with typical TLSS symptoms after the CCL 
procedure are described in greater detail below. 
 
 
Table 1: Observations of 7 patients with transient light-sensitivity syndrome (TLSS) symptoms post-CCL.  
Patient No. 1 2 3 4 5 6 7 
Age  17 28 54 14 16 43 40 
Ethnicity/gender Caucasian Male Hispanic Male Caucasian Female Caucasian Male Caucasian Male Caucasian Female Caucasian Male 
Stage of 
Keratoconus 
Stage 2 Stage 2 Stage 2 Stage 2 Stage 2 Stage 2 Stage 2 
Involved eye OD OD OS OS OS OS OD 
Pre-CLL CDVA 20/40 20/150 20/25 20/25 20/30 20/25 20/25 
Post-CCL CDVA 20/40 20/100 20/25 20/20 20/40 20/25 20/30 
Post-TLSS 20/40 20/100 20/25 20/20 20/40 20/25 20/30 
Kmax (diopter [D]) 55 57 48 58 52 48 60 
Pachymetry 
(micrometer [μm]) 
420 460 530 400 420 495 518 
CCL Procedure EPI-Off 3mW/cm2 
x 30min 
EPI-Off 3mW/cm2 
x 30min 
EPI-Off 3mW/cm2 
x 30min 
EPI-Off 3mW/cm2 
x 30min 
EPI-On 3mW/cm2 
x 30min 
EPI-On 3mW/cm2 
x 30min 
EPI-On 3mW/cm2 
x 30min 
Symptom onset 
post-CCL 
7-wk 10-wk 6-wk 3-wk 6-wk 5-wk 9-wk 
Severity scale* 1 1 2 1 2 1 1 
Subjective dry eye none none none none positive Positive none 
Photosensitivity positive positive positive positive positive positive positive 
SLE none none none none SPK none none 
Corticosteroid 
administered 
Fluorometholone Fluorometholone Fluorometholone Fluorometholone Fluorometholone Fluorometholone Fluorometholone 
Symptom resolution 
after corticosteroid 
therapy 
2-wk 2-wk 1-wk 6-wk 2-wk 1-wk 1-wk 
CDVA: corrected distance visual acuity; CCL: corneal collagen cross-linking; Kmax: maximum keratometric reading; SLE: slit-lamp exam; SPK: superficial punctate keratitis; 
OD: right eye; OS: left eye; min: minute; wk: weeks 
 *Severity scale (0 = no pain, 1 = mild, 2 = moderate, 3 = severe). CCL method includes delivery of 3 milliwatts per square centimeter [mW/cm
2
] irradiance of UVA for 30 min 
(dose= 5.4 joules per centimeter [J/cm]); epithelium was removed for four patients (“EPI-Off”) and the epithelium was kept on for three patients (“EPI-On”). 
Fluorometholone (fluorometholone acetate 0.1%; Alcon; USA). 
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Case 1 
A 54-year-old, Caucasian female presented to our clinic 
with stage 2 keratoconus left eye (OS) (Maximum 
keratometric reading [Kmax]=48 diopter [D], 
pachymetry=530 micrometer [μm]). She was a candidate 
for CCL and consented to undergo the procedure. The 
epithelial layer of the cornea OS was removed (EPI-Off) 
by debridement and CCL was performed with the Avedro 
KXL® system. After the procedure, a standard therapy of 
tapering corticosteroids was administered for four 
weeks. There were no intraoperative complications. 
Before CCL, her CDVA was 20/25, and after CCL, her 
CDVA was 20/25 as well. Six weeks post-CCL, she acutely 
presented to the clinic with moderate photosensitivity 
OS, no subjective dry eye, and with no significant findings 
on slit-lamp exam. Her sensitivity to light resolved after 
one week of fluorometholone (fluorometholone acetate 
0.1%; Alcon; USA) therapy four times a day. After 
treatment of TLSS-like symptoms, her CDVA remained 
20/25 and there was no loss of visual acuity.  
Case 2 
A 40-year-old, Caucasian male presented to us with stage 
2 keratoconus right eye (OD) (Kmax=60 D, 
pachymetry=518 μm) and opted to proceed with CCL. 
The procedure was uneventful with no intraoperative 
complications. The epithelial layer remained intact (EPI-
On), and CCL was performed with the Avedro KXL® 
system. He was prescribed a standard corticosteroid 
regimen tapered over four weeks. Before CCL, his CDVA 
was 20/25, and after CCL, his CDVA was 20/30. Nine 
weeks post-CCL, he presented to the clinic with a one-
day history of mild symptoms of photophobia OD but 
denied dry eye symptoms. On slit-lamp examination, 
external and anterior segments were normal OD. He was 
prescribed fluorometholone (fluorometholone acetate 
0.1%; Alcon; USA) four times a day and his symptoms 
were alleviated within one week. After his symptoms of 
TLSS were relieved, his CDVA did not change and 
presented as 20/30. 
Summary of Clinical Cases 
Among our seven patients with photophobia symptoms 
post-CCL, four had their epithelial layer removed prior to 
CCL, and the other three patients underwent the 
transepithelial method. Symptoms of TLSS acutely 
emerged within a range of five weeks to three months 
post-CCL. All seven patients reported subjective 
photosensitivity that varied in severity, although most 
cases were mild to moderate photophobia. Two patients 
complained of subjective dry eye. All of these patients 
also had no elevations in intraocular pressure (IOP). Slit-
lamp exam was unremarkable for signs of inflammation 
in the anterior chamber (AC) in six cases, and one patient 
had endothelial inflammation on exam. The patient was 
a 16-year-old Caucasian male who presented with 
minimal superficial punctate keratopathy (SPK) and 
moderate photosensitivity OS six-week post-CCL. All 
seven patients were given fluorometholone 
(fluorometholone acetate 0.1%; Alcon; USA) with 
subsequent relief of symptoms within one to six weeks. 
More importantly, none of the seven patients had loss of 
CDVA after treatment of TLSS-like symptoms (Table 1). 
DISCUSSION 
In our patient population, seven patients experienced 
delayed photophobia, similar to symptoms seen in TLSS, 
after undergoing CCL. No definite etiologies are accepted 
for the development of TLSS; however, many theories 
have been proposed giving insight into how the severe 
photophobia symptoms develop in LASIK and SMILE [1-3, 
9]. These propositions describe an underlying 
inflammatory mechanism that may occur in other ocular 
surface procedures, such as in corneal crosslinking 
treatment for keratoconus in our patient population. 
Several studies have reported symptoms of extreme light 
sensitivity after femtosecond flap creation performed 
with LASIK. Stonecipher et al. described a 1% incidence of 
TLSS among the patients who received LASIK with 
femtosecond laser flap creation in their study, especially 
among those who received high initial energy from the 
laser [9]. Similarly, the incidence of TLSS among patients 
who also underwent LASIK using a femtosecond laser 
was 1.3% in a study [3]. Both studies described the 
bilateral photophobia with normal uncorrected distance 
visual acuity (UDVA) with no detectable signs of 
inflammation in the AC, and all patients’ rapidly 
responded to topical corticosteroids, such as 
dexamethasone eye drops. When treated with aggressive 
topical corticosteroid therapy, TLSS symptoms typically 
resolve within a few days or weeks [3, 9]. Cyclosporine 
ophthalmic emulsion 0.05% (Restasis®, Allergan, Irvine, 
CA, USA) and punctal plugs may also be helpful to relieve 
the photophobia symptoms [9]. 
The apparent efficacy of these immunosuppressant 
agents indicates that the etiology of TLSS is likely an 
inflammatory process. Shock-wave exposure to 
keratocytes and corneal nerves with high laser pulse 
energy is a likely cause of the local activation of 
keratocytes [1, 9]. The presence of activated keratocytes 
at the stromal-corneal flap interface seen with confocal 
microscopy in 30% of TLSS patients in their study [3]. 
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Perhaps the inflammatory process involving the activated 
keratocytes causes secondary pain and photophobia in 
patients who underwent CCL. 
Although procedurally different, the structures 
secondarily inflamed in LASIK may be similar to those 
affected in CCL. After femtosecond flap formation, 
peripheral displacement of bubbles created in the 
stromal interface irritates the ciliary body. Resulting 
cytokines migrate to the intersection of the sclera, 
limbus, and iris, producing an inflammatory response [3, 
9]. Within the techniques used for flap formation in 
LASIK, TLSS is identified as a complication specific to the 
use of femtosecond lasers, especially with the use of high 
energies, compared to the use of microkeratome [1, 3, 
11]. Moreover, TLSS has been reported in patients with 
clinical haze after receiving high laser energy exposure 
during LASIK possibly due to subsequent keratocyte 
activation [12]. The occurrence of TLSS after SMILE was 
described and proposed that the development of 
delayed-onset extreme photophobia postoperatively was 
probably due to inflammatory responses, involving 
cytokines and activated keratocytes, beyond the 
disruption of tissues and neural connections from 
lenticule extraction alone [2]. Etiology of TLSS is not 
specific to SMILE or LASIK, as inflammation of common 
nearby structures is a common unifying theme. We 
believe that inflammation of these same structures may 
underlie the photosensitivity seen in our patients after 
CCL. 
Our first theory of the development of delayed-onset 
photophobia in CCL patients involves a cytokine-
mediated, inflammatory mechanism. CCL results in 
lacunar edema and dose-dependent damage to 
keratocytes in the anterior stroma [13-15]. Three to six 
months after a CCL procedure, stromal healing is noted 
with an increase in the density of the extracellular matrix 
(ECM) accompanied by an increased number of activated 
keratocyte nuclei involved in stromal wound healing [4, 
16]. Corneal haze in the stroma has been reported and 
this complication may be due to the activated 
keratocytes that proliferate in the stroma two months 
after CCL [17-19]. Secondary inflammation and stromal 
wound healing continue through 36 months after CCL 
[16]. These findings indicate that secondary inflammation 
may cause the delayed-onset photophobia symptoms by 
an increase in activated keratocytes involved in stromal 
healing. 
Another idea that possibly explains the TLSS-like 
symptoms in patients post-CCL may be direct 
photosensitivity and aggravation of peripheral structures 
by riboflavin excitation in the AC. If riboflavin can 
penetrate through deeper layers of the cornea into the 
AC, there is a theoretical risk of phototoxicity to the iris, 
anterior lens, and other structures of the anterior 
segment (Fig. 1) When riboflavin is irradiated with UVA, 
reactive oxygen species are created that can cause 
cellular damage. For example, treatment of riboflavin 
with a standard 3 mW/cm
2
 irradiance of UVA has been 
shown to damage the endothelial layer and limbal 
epithelial stem cells in thin corneas [20-22]. Endotheliitis 
has been reported in several cases after CCL procedures, 
which further suggests damage to the endothelial layer is 
possible [23, 24]. The topical application of 0.1% 
riboflavin to the cornea resulted in a 0.015% 
concentration of riboflavin in the endothelium, which 
suggests that riboflavin may diffuse through the cornea 
into the AC [25]. Additionally, some studies indicate the 
possibility of retinal phototoxicity due to UVA radiation 
during corneal crosslinking [26, 27]. When riboflavin and 
UVA are applied to a localized area of the porcine cornea, 
the stiffening effect of CCL extends beyond the region in 
which the riboflavin and UVA were applied [28]. Fig. 2 
depicts two theories, an inflammatory mechanism and 
direct phototoxicity of irradiated riboflavin in the AC. We 
speculate that these two interdependent mechanisms 
may be associated with TLSS-like symptoms in patient’s 
post-CCL. 
Limitations of our observational study include the small 
sample size of patients with photophobia symptoms 
observed after CCL procedures at our tertiary 
ophthalmology clinic, possibly resulting in low statistical 
power of our study. Additionally, since all of our seven 
patients observed were treated for stage 2 keratoconus 
with CCL procedures, confounding variables may be 
introduced into our study. Another limitation in our 
methods is that inflammation was determined only by 
slit-lamp exam and was not precisely quantified; confocal 
microscopy and ocular fluorometry were not used to 
examine inflammation and flare in our seven patients. A 
strength of our study is that we are the first group to 
report this clinical observation of transient photophobia 
after CCL procedures. We have observed that TLSS-like 
symptoms occur even with CCL procedures involving the 
epithelium intact or removed. Therefore, these 
postoperative symptoms were not exclusively limited to 
refractive procedures. 
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Figure 1: A typical slit-lamp picture after collagen cross-linking (CCL), indicating presence of riboflavin in the anterior chamber. Courtesy of Dr. Majid 
Moshirfar. 
 
 
 
Figure 2: Two speculated mechanisms of the development of transient light-sensitivity syndrome like symptoms in patients after collagen cross-linking 
(CCL). Figure A indicates a cytokine-mediated process involving activated keratocytes driving inflammation. Figure B indicates the proposed penetration 
of riboflavin into the anterior chamber of the eye during CCL. If riboflavin is excited by UVA light, this may possibly irritate uveal structures and produce 
secondary pain. 
 
CONCLUSION 
Symptoms of TLSS are uncommon, but moderately 
painful, and may be associated with CCL procedures. The 
incidence of TLSS-like symptoms in our patients 
described may be due to a secondary inflammatory 
response involving activated keratocytes and cytokine 
release during tissue remodeling and healing. These 
symptoms may also be associated with possible 
phototoxicity from free radical damage from riboflavin 
and UVA extending into the AC. Further research should 
be conducted on the wound healing process and which 
structures are involved in the inflammatory process in 
CCL procedures in light of the appearance of extremely 
delayed photophobia after treatment, possibly due to 
secondary inflammation. Additionally, more studies 
should be conducted determining the extent of riboflavin 
penetration into the AC, and the factors that may 
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increase the risk of phototoxicity of riboflavin with 
excitation from UVA. There is a possibility that TLSS 
symptoms can occur when using irradiance higher than 3 
mW/cm
2
 UVA with shorter procedure times. Additionally, 
TLSS symptoms may increase if no corticosteroids were 
immediately prescribed postoperatively. The use of 
corticosteroids after CCL, while routine for four weeks, 
may be reintroduced when symptoms of TLSS appear. 
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